LIG Biowise's Series A Round

LIG Biowise raised a round of funding on February 05, 2018. Investors include Phoenix Bridge.

LIG Biowise is a biotechnology company developing an ultra-rapid, point-of-care diagnostic test for infectious diseases. Its platform technology combines DNA extraction, amplification, and detection i…

Articles about LIG Biowise's Series A Round: